| 000 | 01214 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515085931.0 | ||
| 264 | 0 | _c20071109 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a0889-8529 | ||
| 024 | 7 |
_a10.1016/s0889-8529(07)80007-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMayerson, Adam B | |
| 245 | 0 | 0 |
_aLevemir Early Clinical Experience Case Series. _h[electronic resource] |
| 260 |
_bEndocrinology and metabolism clinics of North America _cAug 2007 |
||
| 300 |
_a45-52 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xanalogs & derivatives |
| 650 | 0 | 4 | _aInsulin Detemir |
| 650 | 0 | 4 | _aInsulin, Long-Acting |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tEndocrinology and metabolism clinics of North America _gvol. 36 Suppl 1 _gp. 45-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0889-8529(07)80007-7 _zAvailable from publisher's website |
| 999 |
_c17405915 _d17405915 |
||